Novartis reported $13.03B in Sales Revenues for its fourth fiscal quarter of 2020.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Abbvie ABBV:US $ 13858M 956M
Amgen AMGN:US $ 6634M 211M
Aphria Inc APH:CN C$ 160.53M 14.84M
AstraZeneca AZN:LN 7410M 832M
Astrazeneca AZN:US $ 7410M 832M
Biogen BIIB:US $ 2852.6M 523.5M
Bristol Myers Squibb BMY:US $ 11068M 528M
Canopy Growth Corp WEED:CN C$ 152.53M 17.26M
Catalent CTLT:US $ 910.8M 65.1M
Corcept Therapeutics CORT:US $ 85.74M 0.59M
Eli Lilly And LLY:US $ 7440M 1699.4M
Gilead Sciences GILD:US $ 7421M 844M
GlaxoSmithKline GSK:LN 8739M 93M
Glaxosmithkline GSK:US $ 8739M 93M
Gw Pharmaceuticals GWPH:US $ 137.05M 15.76M
JAZZ PHA JAZZ:US $ 665.52M 64.63M
Johnson & Johnson JNJ:US $ 22475M 1393M
Lannett LCI:US $ 133.92M 7.44M
Merk MRK:US $ 12515M 36M
Perrigo Ordinary Shares PRGO:US $ 1213.7M 5.4M
Pfizer PFE:US $ 11684M 447M
Phibro Animal Health PAHC:US $ 206.15M 10.96M
Prestige Brands PBH:US $ 238.79M 1.37M
Teva Pharmaceutical Industries TEVA:US $ 4454M 476M
Valeant Pharmaceuticals VRX:CN $ 2138M 474M
Zoetis ZTS:US $ 1807M 21M